MTOR and systemic lupus erythematosus: Kyn, as an established endogenous ligand of AhR, can exert anti-inflammatory and immunomodulatory effects through activation of AhR (168) and mTOR (62), and we have previously mentioned that Kyn has a definite effect on SLE.